BMY—Opdivo/Yervoy PDUFA in high-TMB 1L-NSCLC is 2/20/19 (with standard sBLA review): https://news.bms.com/press-release/corporatefinancial-news/us-food-and-drug-administration-fda-accepts-application-opdivo